Evidence map›Paper›PMID 34977571›Full record

ReviewRSC chemical biology2021

Insights into auto-

Lu Hu, Zhipeng Tao, Xu Wu

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in RSC chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. DynamicbioRxiv : the preprint server for biology · 2025
    Article
  5. Review
  6. Metabolic transitions regulate global protein fatty acylation.The Journal of biological chemistry · 2024
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lu HuCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School 149, 13th St. Charlestown MA 02129 USA LHU8@mgh.harvard.edu XWU@CBRC2.mgh.harvard.edu.
Zhipeng TaoCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School 149, 13th St. Charlestown MA 02129 USA LHU8@mgh.harvard.edu XWU@CBRC2.mgh.harvard.edu.
Xu WuCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School 149, 13th St. Charlestown MA 02129 USA LHU8@mgh.harvard.edu XWU@CBRC2.mgh.harvard.edu.ORCID https://orcid.org/0000-0002-1624-0143
Harvard University · US

Funding

Targeting dynamic palmitoylation of TEAD transcription factorsR01CA238270 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI MAO, JUNHAO, WU, XU · 2019 to 2023
$2.7M
Targeting Hippo pathway in melanomaR01CA219814 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WU, XU, ZHENG, BIN · 2019 to 2023
$2.6M
Chemical approach to study autopalmitoylation of transcription factorsR01DK107651 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI LUO, XUELIAN, WU, XU · 2016 to 2020
$1.9M
NCI NIH HHS R01 CA219814NCI NIH HHS R01 CA238270NIDDK NIH HHS R01 DK107651
6 · The paper itself

Abstract

Posttranslational

Identifiers

PMID34977571
PMCPMC8637764
OpenAlexW3193353620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.